Acute myeloid leukemia

Emil J. Freireich

doi:10.1007/978-1-4614-5197-6_19

Acute myeloid leukemia

Emil J. Freireich

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Acute myeloid leukemia (AML) is a systemic disease that is metastatic from diagnosis; therefore, the problems typically associated with local and regional control, i.e., those associated with surgery and radiation therapy, do not play a role. Since virtually all patients who die as a result of a malignant disease die of systemic (metastatic) cancer, AML has served as a prototype illness for the development of systemic therapies, and advances in the control of this disease have been rapidly applied to the control of the more common metastatic cancers in man.

Original language	English (US)
Title of host publication	60 Years of Survival Outcomes at the University of Texas MD Anderson Cancer Center
Publisher	Springer New York
Pages	205-209
Number of pages	5
ISBN (Print)	9781461451976, 1461451965, 9781461451969
DOIs	https://doi.org/10.1007/978-1-4614-5197-6_19
State	Published - Aug 1 2012

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4614-5197-6_19

Cite this

@inbook{1bc55147e878415585593a8972c5a66c,

title = "Acute myeloid leukemia",

abstract = "Acute myeloid leukemia (AML) is a systemic disease that is metastatic from diagnosis; therefore, the problems typically associated with local and regional control, i.e., those associated with surgery and radiation therapy, do not play a role. Since virtually all patients who die as a result of a malignant disease die of systemic (metastatic) cancer, AML has served as a prototype illness for the development of systemic therapies, and advances in the control of this disease have been rapidly applied to the control of the more common metastatic cancers in man.",

author = "Freireich, {Emil J.}",

year = "2012",

month = aug,

day = "1",

doi = "10.1007/978-1-4614-5197-6_19",

language = "English (US)",

isbn = "9781461451976",

pages = "205--209",

booktitle = "60 Years of Survival Outcomes at the University of Texas MD Anderson Cancer Center",

publisher = "Springer New York",

}

TY - CHAP

T1 - Acute myeloid leukemia

AU - Freireich, Emil J.

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Acute myeloid leukemia (AML) is a systemic disease that is metastatic from diagnosis; therefore, the problems typically associated with local and regional control, i.e., those associated with surgery and radiation therapy, do not play a role. Since virtually all patients who die as a result of a malignant disease die of systemic (metastatic) cancer, AML has served as a prototype illness for the development of systemic therapies, and advances in the control of this disease have been rapidly applied to the control of the more common metastatic cancers in man.

AB - Acute myeloid leukemia (AML) is a systemic disease that is metastatic from diagnosis; therefore, the problems typically associated with local and regional control, i.e., those associated with surgery and radiation therapy, do not play a role. Since virtually all patients who die as a result of a malignant disease die of systemic (metastatic) cancer, AML has served as a prototype illness for the development of systemic therapies, and advances in the control of this disease have been rapidly applied to the control of the more common metastatic cancers in man.

UR - http://www.scopus.com/inward/record.url?scp=84929569030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929569030&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-5197-6_19

DO - 10.1007/978-1-4614-5197-6_19

M3 - Chapter

SN - 9781461451976

SN - 1461451965

SN - 9781461451969

SP - 205

EP - 209

BT - 60 Years of Survival Outcomes at the University of Texas MD Anderson Cancer Center

PB - Springer New York

ER -

Acute myeloid leukemia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this